Active Shortage

MOUNJARO

ELI LILLY CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MOUNJARO in Canada?

Yes. MOUNJARO 12.5MG has an active shortage reported to Health Canada (last updated October 15, 2025).

When will MOUNJARO be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Affected strength12.5MG

Report last updated2025-10-15

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ZEPBOUND

ELI LILLY CANADA INC

2.5MG · DIN 02557509

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

MOUNJARO KWIKPEN

ELI LILLY CANADA INC

15MG · DIN 02552000

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02541092

Strength

12.5MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

TIRZEPATIDE

Tier

Unrated

Last Updated

2025-10-15

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from ELI LILLY CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

20MG · DIN 02338327

100MG · DIN 02306433

500MG · DIN 02253437

30MG · DIN 02382369

100UNIT · DIN 02461528

BASAGLAR

100UNIT · DIN 02444844